RNR
抑制剂选择性比较
RNR产品
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1218 |
ClofarabineClofarabine 抑制 ribonucleotide reductase (RNR) (IC50 = 65 nM)和 DNA polymerase 的酶活性。Clofarabine 可诱导自噬和凋亡。 |
![]() ![]() Immunoblot analysis of cell lysates of NCI-H929 cells treated with CLO (5 μM, 3-48 h) GAPDH served as the loading control for each membrane, and data are representative of at least two independent experiments |
|
S7470 |
TriapineTriapine (3-AP) 是一种强效的ribonucleotide reductase (RNR)抑制剂,通过抑制DNA的合成而具有广谱抗肿瘤活性。 |
![]() ![]() (a) Quantification of p-RPA/ Rad51, 53BP1 and γH2AX in GBM01 cells treated with DMSO or triapine. (b) Quantification of p-RPA/Rad51, 53BP1 and γH2AX in GBM02 cells treated with DMSO or triapine.
|
|
S0283New |
COH-29COH29 (RNR Inhibitor COH29) 是一种有效的 ribonucleotide reductase (RNR) 的抑制剂,具有抗癌活性。COH29 (RNR Inhibitor COH29) 在体外抑制重组 RNR small subunit (RRM1/RRM2) 的活性,对应的IC50值为16 μM。 |
||
S3641 |
OsalmidOsalmid suppresses ribonucleotide reductase (RR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM. |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S1218 |
ClofarabineClofarabine 抑制 ribonucleotide reductase (RNR) (IC50 = 65 nM)和 DNA polymerase 的酶活性。Clofarabine 可诱导自噬和凋亡。 |
![]() ![]() Immunoblot analysis of cell lysates of NCI-H929 cells treated with CLO (5 μM, 3-48 h) GAPDH served as the loading control for each membrane, and data are representative of at least two independent experiments |
|
S7470 |
TriapineTriapine (3-AP) 是一种强效的ribonucleotide reductase (RNR)抑制剂,通过抑制DNA的合成而具有广谱抗肿瘤活性。 |
![]() ![]() (a) Quantification of p-RPA/ Rad51, 53BP1 and γH2AX in GBM01 cells treated with DMSO or triapine. (b) Quantification of p-RPA/Rad51, 53BP1 and γH2AX in GBM02 cells treated with DMSO or triapine.
|
|
S0283New |
COH-29COH29 (RNR Inhibitor COH29) 是一种有效的 ribonucleotide reductase (RNR) 的抑制剂,具有抗癌活性。COH29 (RNR Inhibitor COH29) 在体外抑制重组 RNR small subunit (RRM1/RRM2) 的活性,对应的IC50值为16 μM。 |
||
S3641 |
OsalmidOsalmid suppresses ribonucleotide reductase (RR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM. |